Required Reading
|

Required Reading

Republicans fast track plan to undo Obama regulations Obama pleads with Democrats to save healthcare legacy Obamacare repeal would cost New York at least $3.7 billion: governor Fed policymakers agree Trump fiscal boost poses inflation risk New York train crash injures more than 100 commuters Exclusive: Amazon, Forever 21 vying for bankrupt American Apparel –…

Chart Of The Day: Another Money-Losing Biotech Plunges After Lousy Phase 3 Study

Chart Of The Day: Another Money-Losing Biotech Plunges After Lousy Phase 3 Study

Agile Therapeutics (AGRX) plunged after it said a Phase 3 study of its Twirla contraceptive patch scored a 4.8 using the Pearl Index, an index that shows the number of times the contraceptive fails over a calculated 100 years of use, worse than a competitors Pearl Index score of 3.19.